August 31, 2017 Columns by Laura Kolaczkowski Ocrevus and Sweating Out MS Many of you are considering making the switch to Ocrevus (ocrelizumab) as your disease-modifying therapy for multiple sclerosis. This is a switch I made recently. There are so many questions and unknowns…
August 24, 2017 Columns by Laura Kolaczkowski MS Advocacy Resources are Many Advocacy comes in many forms, and recently I wrote about what advocacy by individuals might look like. The other type of advocacy we have going for those of us with multiple sclerosis is the work done…
August 17, 2017 Columns by Laura Kolaczkowski Digging Deeper for a Cure I stood at the front door of my house and could only shake my head as I watched the backhoe digging a deep trench in my yard. A sewer line malfunction created a mess in my basement…
August 10, 2017 Columns by Laura Kolaczkowski Faces of MS Advocacy Do you ever stop to wonder about the people who write these great columns for Multiple Sclerosis News Today? I have the honor of knowing several of them via telephone conversations and even occasional in-person meetings. You…
August 3, 2017 Columns by Laura Kolaczkowski The Importance of Patients Having a Voice in MS Research I recently spent time at the annual meeting of the Drug Information Association (DIA), listening to presentations and talking with industry representatives about the multiple sclerosis community’s needs. DIA is a nonprofit association that has been around more…
July 27, 2017 Columns by Laura Kolaczkowski Got Questions? iConquerMS Seeks Answers If you’ve followed my writing, you already know I am committed to advancing patient-centered research and care. I am the lead patient representative and co-principal investigator for iConquerMS. One of the main goals of iConquerMS is to…
July 13, 2017 Columns by Laura Kolaczkowski Ocrevus and Me, Part 2: Infusion Time and Side Effects Editor’s note: This column is second in a series. Read the first part here. Just you wait! How many times have we heard those words or said them to someone else? I find that now it’s…
July 6, 2017 Columns by Laura Kolaczkowski Ocrevus and Me I’ve done it! I made the treatment switch that so many people with multiple sclerosis are talking about: I said goodbye to Tysabri (natalizumab) and am now on Ocrevus (ocrelizumab) as my disease-modifying therapy…
June 15, 2017 Columns by Laura Kolaczkowski A Looming Crisis in MS Research and Care Editor’s note: Patient columnist Laura Kolaczkowski attended the 31st annual Consortium of Multiple Sclerosis Centers conference in New Orleans. We’re facing a major problem in the near future due to a shortage of researchers for multiple…
June 8, 2017 Columns by Laura Kolaczkowski CMSC Revises Recommendations for Gadolinium Use in MRIs Editor’s note: Patient columnist Laura Kolaczkowski attended the 31st annual Consortium of Multiple Sclerosis Centers conference in New Orleans. The information in this article was taken from an interview session with the physicians. The use of…
June 1, 2017 Columns by Laura Kolaczkowski MS Comprehensive Care: What My Clinic Teammates are Doing I couldn’t help but smile when I saw “MS Comprehensive Care: A Team Sport“ listed as the title of the John F. Kurtzke Memorial Lecture at the opening of the Consortium of MS Centers 2017 Annual Meeting.
May 18, 2017 Columns by Laura Kolaczkowski Defining Resiliency in MS and Ideas on Bouncing Back How well do you bounce back when MS gets you down? An article called “Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis” caught my attention because bouncing back is something I don’t…
April 29, 2024 Columns by Leigh Anne Nelson My biggest worry post-diagnosis was whether MS could be inherited
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression